Back

Evidence-based medications in multi-ethnic Asian patients with heart failure are associated with better outcomes in spite of lower doses

23 May 2016 (08:54 - 09:00)
Organised by:
Congress Presentation Part of: Rapid Fire 3 - Chronic heart failure management Chronic nursing care HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Tiew-Hwa Katherine Teng

National Heart Centre Singapore, Singapore (Singapore)

13 More presentations in this session

Presentation thumbnail
Morbidity, mortality, and cost impact of stage b and stage c heart failure: comparative analysis to underline the clinical and economic need for heart failure prevention strategy.
Doctor S. James (Castlebar, IE)
Abstract Slides
Presentation thumbnail
Effects of 5 years treatment with nebivolol, carvedilol and bisoprolol in heart failure patients
Doctor G. Marazzi (Rome, IT)
Abstract
Presentation thumbnail
MTP-131, a cardiolipin-targeting peptide, improves mitochondrial activity in the failing human heart
Doctor B. Stauffer (Aurora, US)
Abstract Slides
Presentation thumbnail
Is the cohort of paradigm-hf representative of the real world population of patients with systolic heart failure?
Doctor G. Rocha Rodrigues (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Improving the quality of heart failure care: secular trends at a regional center of excellence
Professor S. Stoerk (Wuerzburg, DE)
Abstract

Access the full session

Session thumbnail
Rapid Fire 3 - Chronic heart failure management

The Event

Event poster

HEART FAILURE 2016

23 May 2016 08:54 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources